How We Engage

External collaborations play an essential role in helping us deliver a breakthrough portfolio for patients. That starts with new ideas and new science. We believe that through solving problems scientist-to-scientist, we can learn from each other to develop the next generation of medicines. And we are building relationships across the innovation community in a number of ways: from support for young scientific entrepreneurs and start-ups through our ‘Grass Roots’ program of activities, to joint partnerships with academia and industry, to new models of partnering such as our SHINE program and scientific crowdsourcing. However we choose to work together, our broad range of partnering and investment models are customized for each project – always driven by the science. This is supplemented by our ongoing Corporate Venture Fund Activities which continue to drive innovation through strategic investment in early-stage science and technology.